For a Good Cause | GenomeWeb

For a Good Cause

23andme is expanding its 23andWe initiative, which aims to acquire detailed health and trait data from existing customers, by recruiting 10,000 Parkinson's disease patients for a targeted analysis of the genetic and environmental causes of this disease. The program, backed in part by the Michael J. Fox Foundation, was announced on the 23andMe blog. Parkinson's patients get access to the full features of a 23andMe genome scan for $25 in return for participation in online surveys.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.